BNP Paribas SAผลกระทบต่อหุ้น 3
BNP Paribas SA
Carlyle Group Inc
Theon International PlcTHEON enters exclusivity to acquire HGH for €300M, expected to be EPS accretive in 2027, broadening its portfolio.
ผลกระทบต่อธีม 2
บริษัทนอก coverage 2
HGH is the acquisition target; the deal values it at €300M, reflecting its strong growth and margins.
SAS Stéropès is the holding company being acquired; the deal implies a positive valuation for its shareholders.